Cibc World Market Inc. reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 18.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 357,081 shares of the healthcare conglomerate's stock after selling 80,663 shares during the period. Cibc World Market Inc.'s holdings in UnitedHealth Group were worth $131,077,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Nvwm LLC lifted its holdings in shares of UnitedHealth Group by 89.2% during the 3rd quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate's stock valued at $26,000 after buying an additional 33 shares during the period. Wellington Altus USA Inc. raised its position in UnitedHealth Group by 97.1% during the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate's stock valued at $28,000 after purchasing an additional 33 shares during the period. Security National Bank of SO Dak bought a new stake in UnitedHealth Group in the second quarter worth about $29,000. Compass Wealth Management LLC purchased a new stake in UnitedHealth Group in the 3rd quarter valued at about $29,000. Finally, Aberdeen Wealth Management LLC bought a new position in UnitedHealth Group during the 2nd quarter worth about $31,000. 87.86% of the stock is owned by institutional investors.
UnitedHealth Group Stock Performance
NYSE:UNH opened at $389.45 on Wednesday. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The company has a fifty day simple moving average of $391.42 and a two-hundred day simple moving average of $366.73. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The company has a market cap of $348.96 billion, a price-to-earnings ratio of 22.24, a price-to-earnings-growth ratio of 1.49 and a beta of 0.51.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.14 by $0.55. The firm had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. UnitedHealth Group's revenue was down .4% compared to the same quarter last year. During the same period last year, the business posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be paid a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Monday, December 7th. UnitedHealth Group's dividend payout ratio is presently 53.00%.
Key Headlines Impacting UnitedHealth Group
These are some of the UNH headlines that stood out recently:
- Positive Sentiment: UnitedHealth appointed longtime healthcare executive Madeline S. Bell to its board, a move that may focus investor attention on governance and long-term capital allocation. Read article
- Neutral Sentiment: A report says Meridiem Capital Partners sold its UnitedHealth shares in the third quarter. This is a limited, backward-looking signal from one fund, rather than evidence of a broad investor retreat. Read article
- Negative Sentiment: Sen. Elizabeth Warren called for breaking up major healthcare conglomerates, while coverage also cited a Senate breakup bill. The prospect of structural changes adds policy uncertainty for UnitedHealth and contributed to selling pressure. Read article
Analyst Ratings Changes
Several research analysts recently weighed in on UNH shares. UBS Group restated an "outperform" rating on shares of UnitedHealth Group in a research note on Tuesday, October 13th. Stephens set a $500.00 price objective on shares of UnitedHealth Group in a report on Friday, October 16th. TD Cowen restated a "hold" rating and issued a $402.00 price objective on shares of UnitedHealth Group in a report on Thursday, October 15th. KeyCorp reiterated an "overweight" rating on shares of UnitedHealth Group in a report on Wednesday, October 14th. Finally, Zacks Research cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Monday, September 14th. Twenty equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus price target of $463.93.
Check Out Our Latest Stock Report on UNH
Insiders Place Their Bets
In related news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.19% of the stock is currently owned by company insiders.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.